These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 23398932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
    Bonificio A, Ghartey-Tagoe E, Gallorini S, Baudner B, Chen G, Singh P, O'Hagan DT, Kommareddy S.
    Vaccine; 2015 Jun 09; 33(25):2930-8. PubMed ID: 25930118
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preparation of highly concentrated influenza vaccine for use in novel delivery approaches.
    Kommareddy S, Bonificio A, Gallorini S, Baudner B, Singh M, O'Hagan D.
    J Pharm Sci; 2013 Mar 09; 102(3):866-75. PubMed ID: 23303584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    Saluja V, Visser MR, Ter Veer W, van Roosmalen ML, Leenhouts K, Hinrichs WL, Huckriede A, Frijlink HW.
    Vaccine; 2010 Nov 23; 28(50):7963-9. PubMed ID: 20946860
    [Abstract] [Full Text] [Related]

  • 11. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y, Palladino G, Xie Y, Ferrari A, Settembre EC.
    Vaccine; 2018 May 17; 36(21):3010-3017. PubMed ID: 29680201
    [Abstract] [Full Text] [Related]

  • 12. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity.
    Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR.
    J Control Release; 2010 Mar 03; 142(2):187-95. PubMed ID: 19840825
    [Abstract] [Full Text] [Related]

  • 13. Long-term stability of influenza vaccine in a dissolving microneedle patch.
    Mistilis MJ, Joyce JC, Esser ES, Skountzou I, Compans RW, Bommarius AS, Prausnitz MR.
    Drug Deliv Transl Res; 2017 Apr 03; 7(2):195-205. PubMed ID: 26926241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch.
    Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR.
    Eur J Pharm Biopharm; 2012 Jun 03; 81(2):239-47. PubMed ID: 22504442
    [Abstract] [Full Text] [Related]

  • 19. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens.
    Kommareddy S, Baudner BC, Oh S, Kwon SY, Singh M, O'Hagan DT.
    J Pharm Sci; 2012 Mar 03; 101(3):1021-7. PubMed ID: 22190403
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.